Atlas Trials

Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma

Clinical trial NCT03376737 · UNKNOWN

Trial details

NCT number
NCT03376737
Sponsor
Henan Cancer Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Adenocarcinoma
Start date
2017-10-12
Primary completion
2018-06-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.